Breaking News Instant updates and real-time market news.

KLAC

KLA Corp.

$341.17 /

-0.985 (-0.29%)

09:18
10/28/21
10/28
09:18
10/28/21
09:18

KLA Corp. price target raised to $400 from $390 at Needham

Needham analyst N. Quinn Bolton raised the firm's price target on KLA Corp. to $400 from $390 and keeps a Buy rating on the shares. The analyst cites the company's "strong" beat and raise quarter amid continued WFE sales mix shift to foundry/logic. The bulls will see KLA's print as further evidence that WFE could reach about $100B next year, and even the bears will have to admit that the company is likely going to outperform WFE for the second consecutive year, Bolton tells investors in a research note.

  • 28

    Oct

  • 03

    Nov

  • 30

    Nov

KLAC KLA Corp.
$341.17 /

-0.985 (-0.29%)

10/28/21 Credit Suisse
KLA Corp. price target raised to $430 from $380 at Credit Suisse
10/28/21 Wells Fargo
KLA Corp. price target raised to $360 from $345 at Wells Fargo
10/28/21 Susquehanna
KLA Corp. price target raised to $490 from $475 at Susquehanna
10/28/21 Deutsche Bank
KLA Corp. price target raised to $420 from $400 at Deutsche Bank

TODAY'S FREE FLY STORIES

Earnings
Daktronics reports Q2 EPS 5c vs. 8c last year » 07:34
12/01/21
12/01
07:34
12/01/21
07:34
DAKT

Daktronics

$4.92 /

+0.1 (+2.07%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DAKT Daktronics
$4.92 /

+0.1 (+2.07%)

DAKT Daktronics
$4.92 /

+0.1 (+2.07%)

Hot Stocks
Statera BioPharma announces lift of clinical hold on entolimod » 07:33
12/01/21
12/01
07:33
12/01/21
07:33
STAB

Statera BioPharma

$2.92 /

-0.23 (-7.30%)

Statera Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STAB Statera BioPharma
$2.92 /

-0.23 (-7.30%)

STAB Statera BioPharma
$2.92 /

-0.23 (-7.30%)

Recommendations
Blueprint Medicines added to Analyst Current Favorites list at Raymond James » 07:32
12/01/21
12/01
07:32
12/01/21
07:32
BPMC

Blueprint Medicines

$96.10 /

-2.3 (-2.34%)

, RGNX

Regenxbio

$32.00 /

+1.785 (+5.91%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPMC Blueprint Medicines
$96.10 /

-2.3 (-2.34%)

RGNX Regenxbio
$32.00 /

+1.785 (+5.91%)

BPMC Blueprint Medicines
$96.10 /

-2.3 (-2.34%)

11/29/21 Stifel
Stifel expects neutral reaction for Blueprint acquisition of Lengo Therapeutics
11/29/21 Piper Sandler
Blueprint acquisition may surprise investors looking for buyout, says Piper
11/19/21 Morgan Stanley
Blueprint Medicines assumed with an Equal Weight at Morgan Stanley
10/28/21 Stifel
Stifel raises Blueprint Medicines target to $108 given faster Ayvakit launch
RGNX Regenxbio
$32.00 /

+1.785 (+5.91%)

10/25/21 Roth Capital
Clearside Biomedical price target raised to $17 from $15 at Roth Capital
10/19/21 Morgan Stanley
Regenxbio assumed with an Overweight at Morgan Stanley
10/04/21 Roth Capital
Clearside injector de-risked by Regenxbio data, says Roth Capital
09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
BPMC Blueprint Medicines
$96.10 /

-2.3 (-2.34%)

RGNX Regenxbio
$32.00 /

+1.785 (+5.91%)

  • 08
    Jan
RGNX Regenxbio
$32.00 /

+1.785 (+5.91%)

Recommendations
Zscaler price target raised to $418 from $390 at Needham » 07:32
12/01/21
12/01
07:32
12/01/21
07:32
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

Needham analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

07:21 Today Morgan Stanley
Zscaler price target raised to $330 from $275 at Morgan Stanley
07:14 Today BMO Capital
Zscaler price target raised to $415 from $315 at BMO Capital
07:03 Today Baird
Zscaler price target raised to $415 from $325 at Baird
06:59 Today Wolfe Research
Zscaler price target raised to $400 from $325 at Wolfe Research
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Hot Stocks
Gran Colombia Gold announces updates mineral resource estimate » 07:31
12/01/21
12/01
07:31
12/01/21
07:31
TPRFF

Gran Colombia Gold

$3.93 /

-0.11 (-2.72%)

GCM Mining announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TPRFF Gran Colombia Gold
$3.93 /

-0.11 (-2.72%)

TPRFF Gran Colombia Gold
$3.93 /

-0.11 (-2.72%)

09/28/21 Canaccord
Gran Colombia Gold initiated with a Buy at Canaccord
Hot Stocks
Ironwood appoints Sravan Emany as CFO » 07:31
12/01/21
12/01
07:31
12/01/21
07:31
IRWD

Ironwood

$11.09 /

+0.225 (+2.07%)

Ironwood announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRWD Ironwood
$11.09 /

+0.225 (+2.07%)

IRWD Ironwood
$11.09 /

+0.225 (+2.07%)

02/09/21 Gordon Haskett
Ironwood odds of sale improved with CEO exit, says Gordon Haskett
IRWD Ironwood
$11.09 /

+0.225 (+2.07%)

Hot Stocks
PureTech Health says weight management approach Plenity widely available » 07:30
12/01/21
12/01
07:30
12/01/21
07:30
PRTC

PureTech Health

$43.04 /

+ (+0.00%)

PureTech Health noted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRTC PureTech Health
$43.04 /

+ (+0.00%)

PRTC PureTech Health
$43.04 /

+ (+0.00%)

08/25/21 Piper Sandler
PureTech Health price target lowered to $72 from $76 at Piper Sandler
02/10/21 Piper Sandler
PureTech Health price target raised to $76 from $66 at Piper Sandler
01/15/21 SVB Leerink
PureTech Health initiated with an Outperform at SVB Leerink
PRTC PureTech Health
$43.04 /

+ (+0.00%)

PRTC PureTech Health
$43.04 /

+ (+0.00%)

Hot Stocks
The Digital IF Interoperability Consortium announces six new members » 07:30
12/01/21
12/01
07:30
12/01/21
07:30
KTOS

Kratos Defense

$19.73 /

-0.245 (-1.23%)

, MSFT

Microsoft

$330.66 /

-5.88 (-1.75%)

The Digital IF…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KTOS Kratos Defense
$19.73 /

-0.245 (-1.23%)

MSFT Microsoft
$330.66 /

-5.88 (-1.75%)

KTOS Kratos Defense
$19.73 /

-0.245 (-1.23%)

10/21/21 RBC Capital
RBC starts Kratos Defense with an Outperform rating, $28 target
10/21/21 RBC Capital
Kratos Defense initiated with an Outperform at RBC Capital
10/15/21 Truist
Kratos Defense price target lowered to $24 from $26 at Truist
08/16/21 Canaccord
Kratos' Valkyrie remains only aircraft that meets Skyborg needs, says Canaccord
MSFT Microsoft
$330.66 /

-5.88 (-1.75%)

11/22/21 Wells Fargo
Wells Fargo starts Microsoft with Overweight, $400 target on 'bright future'
11/22/21 Wells Fargo
Microsoft initiated with an Overweight at Wells Fargo
11/19/21 UBS
Zoom Video price target lowered to $285 from $315 at UBS
11/16/21 Credit Suisse
Microsoft assumed with an Outperform at Credit Suisse
KTOS Kratos Defense
$19.73 /

-0.245 (-1.23%)

MSFT Microsoft
$330.66 /

-5.88 (-1.75%)

MSFT Microsoft
$330.66 /

-5.88 (-1.75%)

KTOS Kratos Defense
$19.73 /

-0.245 (-1.23%)

MSFT Microsoft
$330.66 /

-5.88 (-1.75%)

MSFT Microsoft
$330.66 /

-5.88 (-1.75%)

Hot Stocks
Atlantic Coastal Acquisition Corporation (Units) trading resumes  07:30
12/01/21
12/01
07:30
12/01/21
07:30
 
Hot Stocks
Atlantic Coastal Acquisition Corporation (Class A Stock) trading resumes  07:30
12/01/21
12/01
07:30
12/01/21
07:30
ACAH

Atlantic Coastal Acquisition

$9.75 /

+ (+0.00%)

 
ShowHide Related Items >><<
ACAH Atlantic Coastal Acquisition
$9.75 /

+ (+0.00%)

Hot Stocks
SAB Biotherapeutics Inc trading resumes  07:30
12/01/21
12/01
07:30
12/01/21
07:30
SABS

SAB Biotherapeutics

$10.90 /

+0.65 (+6.34%)

 
ShowHide Related Items >><<
SABS SAB Biotherapeutics
$10.90 /

+0.65 (+6.34%)

SABS SAB Biotherapeutics
$10.90 /

+0.65 (+6.34%)

11/05/21
Fly Intel: Top five analyst initiations
11/05/21 Chardan
SAB Biotherapeutics initiated with a Buy at Chardan
11/02/21
Fly Intel: Top five analyst initiations
11/02/21 Baird
Baird starts SAB Biotherapeutics at Outperform on near-term catalysts
SABS SAB Biotherapeutics
$10.90 /

+0.65 (+6.34%)

Hot Stocks
Cazoo launches service in France, Germany » 07:29
12/01/21
12/01
07:29
12/01/21
07:29
CZOO

Cazoo

$8.06 /

-0.1 (-1.23%)

Cazoo announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CZOO Cazoo
$8.06 /

-0.1 (-1.23%)

CZOO Cazoo
$8.06 /

-0.1 (-1.23%)

09/15/21
Fly Intel: Top five analyst initiations
09/15/21 Citi
Cazoo initiated with a Buy at Citi
CZOO Cazoo
$8.06 /

-0.1 (-1.23%)

Recommendations
Ambarella price target raised to $225 from $220 at Needham » 07:29
12/01/21
12/01
07:29
12/01/21
07:29
AMBA

Ambarella

$180.08 /

-1.835 (-1.01%)

, SSNLF

Samsung

$57.75 /

+ (+0.00%)

, RIVN

Rivian Automotive

$119.72 /

-0.24 (-0.20%)

Needham analyst N. Quinn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

SSNLF Samsung
$57.75 /

+ (+0.00%)

RIVN Rivian Automotive
$119.72 /

-0.24 (-0.20%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

07:21 Today Wells Fargo
Ambarella price target raised to $185 from $115 at Wells Fargo
07:19 Today KeyBanc
Ambarella price target raised to $230 from $185 at KeyBanc
07:16 Today Roth Capital
Ambarella price target raised to $260 from $225 at Roth Capital
06:59 Today Baird
Ambarella price target raised to $200 from $125 at Baird
SSNLF Samsung
$57.75 /

+ (+0.00%)

10/25/21 Roth Capital
Roth Capital 'highly encouraged' by Netlist's favorable Samsung court ruling
10/25/21 Bernstein
Samsung initiated with an Underperform at Bernstein
10/25/21 Bernstein
Micron initiated with an Underperform at Bernstein
10/12/21 Lynx
Lynx still bearish on Micron, would not be stepping in on long side
RIVN Rivian Automotive
$119.72 /

-0.24 (-0.20%)

07:19 Today KeyBanc
Ambarella price target raised to $230 from $185 at KeyBanc
AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

SSNLF Samsung
$57.75 /

+ (+0.00%)

  • 10
    Nov
SSNLF Samsung
$57.75 /

+ (+0.00%)

RIVN Rivian Automotive
$119.72 /

-0.24 (-0.20%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

SSNLF Samsung
$57.75 /

+ (+0.00%)

RIVN Rivian Automotive
$119.72 /

-0.24 (-0.20%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

RIVN Rivian Automotive
$119.72 /

-0.24 (-0.20%)

Initiation
D2L initiated with an Outperform at Raymond James » 07:29
12/01/21
12/01
07:29
12/01/21
07:29
DTOL.TO

D2L

/

+

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DTOL.TO D2L
/

+

11/23/21 TD Securities
D2L initiated with a Buy at TD Securities
11/23/21 BMO Capital
D2L initiated with a Market Perform at BMO Capital
Upgrade
Adevinta upgraded to Neutral from Sell at UBS » 07:29
12/01/21
12/01
07:29
12/01/21
07:29
ADEVF

Adevinta

$16.45 /

+ (+0.00%)

UBS analyst Adam Berlin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADEVF Adevinta
$16.45 /

+ (+0.00%)

11/26/21 Barclays
Adevinta price target lowered to NOK 185 from NOK 200 at Barclays
11/23/21 Morgan Stanley
Adevinta price target lowered to NOK 173 from NOK 185 at Morgan Stanley
11/03/21 Kepler Cheuvreux
Adevinta upgraded to Buy from Hold at Kepler Cheuvreux
10/28/21 Nordea
Adevinta downgraded to Hold from Buy at Nordea
ADEVF Adevinta
$16.45 /

+ (+0.00%)

Hot Stocks
First Advantage completes acquisition of Corporate Screening Services » 07:27
12/01/21
12/01
07:27
12/01/21
07:27
FA

First Advantage

$17.38 /

-0.67 (-3.71%)

First Advantage announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FA First Advantage
$17.38 /

-0.67 (-3.71%)

FA First Advantage
$17.38 /

-0.67 (-3.71%)

11/23/21 Jefferies
HireRight initiated with a Buy at Jefferies
10/18/21 Morgan Stanley
Sterling Check initiated with an Equal Weight at Morgan Stanley
10/18/21 Stifel
Sterling Check initiated with a Buy at Stifel
08/16/21 Citi
First Advantage price target raised to $28.50 from $25 at Citi
FA First Advantage
$17.38 /

-0.67 (-3.71%)

  • 11
    Nov
  • 23
    Jun
FA First Advantage
$17.38 /

-0.67 (-3.71%)

Hot Stocks
Soluna Holdings files universal shelf offering » 07:27
12/01/21
12/01
07:27
12/01/21
07:27
SLNH

Soluna Holdings

$12.04 /

-0.51 (-4.06%)

Soluna Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLNH Soluna Holdings
$12.04 /

-0.51 (-4.06%)

Hot Stocks
LabCorp, ConcertAI enter precision oncology research collaboration » 07:27
12/01/21
12/01
07:27
12/01/21
07:27
LH

LabCorp

$285.29 /

-6.57 (-2.25%)

Labcorp and ConcertAI…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LH LabCorp
$285.29 /

-6.57 (-2.25%)

LH LabCorp
$285.29 /

-6.57 (-2.25%)

10/19/21 Citi
Citi opens 'Positive Catalyst watches' on Quest, LabCorp
08/20/21 Credit Suisse
LabCorp price target raised to $336 from $295 at Credit Suisse
08/19/21 Mizuho
LabCorp price target raised to $332 from $318 at Mizuho
07/30/21 Truist
LabCorp price target raised to $350 from $330 at Truist
LH LabCorp
$285.29 /

-6.57 (-2.25%)

LH LabCorp
$285.29 /

-6.57 (-2.25%)

LH LabCorp
$285.29 /

-6.57 (-2.25%)

LH LabCorp
$285.29 /

-6.57 (-2.25%)

Hot Stocks
Virios achieves over 50% enrollment milestone in its FM Phase 2b clinical trial » 07:27
12/01/21
12/01
07:27
12/01/21
07:27
VIRI

Virios Therapeutics

$5.45 /

+0.56 (+11.45%)

Virios Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIRI Virios Therapeutics
$5.45 /

+0.56 (+11.45%)

  • 17
    Dec
VIRI Virios Therapeutics
$5.45 /

+0.56 (+11.45%)

Hot Stocks
American Lithium intersects Lithium-bearing claystone at TLC North » 07:26
12/01/21
12/01
07:26
12/01/21
07:26
LIACF

American Lithium

$4.24 /

-0.21 (-4.72%)

American Lithium announce…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LIACF American Lithium
$4.24 /

-0.21 (-4.72%)

11/09/21 Roth Capital
American Lithium initiated with a Buy at Roth Capital
Hot Stocks
SAB Biotherapeutics Inc trading halted, news pending  07:25
12/01/21
12/01
07:25
12/01/21
07:25
SABS

SAB Biotherapeutics

$10.90 /

+0.65 (+6.34%)

 
ShowHide Related Items >><<
SABS SAB Biotherapeutics
$10.90 /

+0.65 (+6.34%)

SABS SAB Biotherapeutics
$10.90 /

+0.65 (+6.34%)

11/05/21
Fly Intel: Top five analyst initiations
11/05/21 Chardan
SAB Biotherapeutics initiated with a Buy at Chardan
11/02/21
Fly Intel: Top five analyst initiations
11/02/21 Baird
Baird starts SAB Biotherapeutics at Outperform on near-term catalysts
SABS SAB Biotherapeutics
$10.90 /

+0.65 (+6.34%)

Hot Stocks
Atlantic Coastal Acquisition Corporation (Units) trading halted, news pending  07:25
12/01/21
12/01
07:25
12/01/21
07:25
 
Hot Stocks
Atlantic Coastal Acquisition Corporation (Class A Stock) trading halted, news pending  07:25
12/01/21
12/01
07:25
12/01/21
07:25
ACAH

Atlantic Coastal Acquisition

$9.75 /

+ (+0.00%)

 
ShowHide Related Items >><<
ACAH Atlantic Coastal Acquisition
$9.75 /

+ (+0.00%)

Recommendations
GlobalFoundries price target raised to $80 from $75 at Credit Suisse » 07:25
12/01/21
12/01
07:25
12/01/21
07:25
GFS

GlobalFoundries

$69.42 /

-1.05 (-1.49%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

06:52 Today Deutsche Bank
GlobalFoundries price target raised to $78 from $75 at Deutsche Bank
11/22/21
Fly Intel: Top five analyst initiations
11/22/21 HSBC
GlobalFoundries initiated with a Hold at HSBC
11/22/21 BofA
BofA starts GlobalFoundries at Buy, sees 40% upside potential
GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

  • 28
    Oct
GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

Hot Stocks
Exxon Mobil to maintain capital investments of $20B-$25B through 2027 » 07:25
12/01/21
12/01
07:25
12/01/21
07:25
XOM

Exxon Mobil

$59.80 /

-1.76 (-2.86%)

ExxonMobil said it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XOM Exxon Mobil
$59.80 /

-1.76 (-2.86%)

XOM Exxon Mobil
$59.80 /

-1.76 (-2.86%)

11/02/21
Fly Intel: Top five analyst downgrades
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
10/21/21 Morgan Stanley
Exxon Mobil, Chevron look poised for 'catch up trade,' says Morgan Stanley
XOM Exxon Mobil
$59.80 /

-1.76 (-2.86%)

XOM Exxon Mobil
$59.80 /

-1.76 (-2.86%)

XOM Exxon Mobil
$59.80 /

-1.76 (-2.86%)

XOM Exxon Mobil
$59.80 /

-1.76 (-2.86%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.